Search research articles
Contact Us
Filters
Showing results (1-10 of 172) with videos related to
Page
of 18
Sort By:
Expert Review of Anticancer Therapy
|
May 4, 2011
Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck
Jean-Pascal Machiels, Sandra Schmitz
Current Treatment Options in Oncology
|
June 6, 2016
Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck
Sandra Schmitz, Jean-Pascal Machiels
Hematology/Oncology Clinics of North America
|
November 17, 2015
Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck
Jean-Pascal Machiels, Sandra Schmitz
Acta Clinica Belgica
|
July 6, 2016
Treatment landscape of metastatic prostate cancer: the role of radium-223
Alexandre Dermine, Jean-Pascal Machiels
Expert Review of Anticancer Therapy
|
September 15, 2010
Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications
Sandra Schmitz, Jean-Pascal Machiels
Recent Patents on Anti-Cancer Drug Discovery
|
June 13, 2009
Targeted therapies in the treatment of advanced renal cell carcinoma
Emmanuel Seront, Jean-Pascal Machiels
Current Opinion in Oncology
|
March 6, 2026
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma
Rachel Galot, Jean-Pascal Machiels
Anti-Cancer Drugs
|
November 5, 2010
New advances in targeted therapies for squamous cell carcinoma of the head and neck
Jean-Pascal Machiels, Sandra Schmitz
Current Opinion in Oncology
|
March 2, 2011
Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy
Jean-Pascal Machiels, Sandra Schmitz
Expert Opinion on Drug Safety
|
August 27, 2016
Safety of drug treatments for head and neck cancer
Rachel Galot, Jean-Pascal Machiels
Page
of 18
Search research articles
Search
Showing results (1-10 of 172) with videos related to
Sort By:
Page
of 18
Expert Review of Anticancer Therapy
|
May 4, 2011
Management and palliative chemotherapy for metastatic or recurrent squamous cell carcinoma of the head and neck
Jean-Pascal Machiels, Sandra Schmitz
Current Treatment Options in Oncology
|
June 6, 2016
Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck
Sandra Schmitz, Jean-Pascal Machiels
Hematology/Oncology Clinics of North America
|
November 17, 2015
Epidermal Growth Factor Receptor Inhibition in Squamous Cell Carcinoma of the Head and Neck
Jean-Pascal Machiels, Sandra Schmitz
Acta Clinica Belgica
|
July 6, 2016
Treatment landscape of metastatic prostate cancer: the role of radium-223
Alexandre Dermine, Jean-Pascal Machiels
Expert Review of Anticancer Therapy
|
September 15, 2010
Molecular biology of squamous cell carcinoma of the head and neck: relevance and therapeutic implications
Sandra Schmitz, Jean-Pascal Machiels
Recent Patents on Anti-Cancer Drug Discovery
|
June 13, 2009
Targeted therapies in the treatment of advanced renal cell carcinoma
Emmanuel Seront, Jean-Pascal Machiels
Current Opinion in Oncology
|
March 6, 2026
Circulating tumor DNA in human papilloma virus negative head and neck squamous cell carcinoma
Rachel Galot, Jean-Pascal Machiels
Anti-Cancer Drugs
|
November 5, 2010
New advances in targeted therapies for squamous cell carcinoma of the head and neck
Jean-Pascal Machiels, Sandra Schmitz
Current Opinion in Oncology
|
March 2, 2011
Molecular-targeted therapy of head and neck squamous cell carcinoma: beyond cetuximab-based therapy
Jean-Pascal Machiels, Sandra Schmitz
Expert Opinion on Drug Safety
|
August 27, 2016
Safety of drug treatments for head and neck cancer
Rachel Galot, Jean-Pascal Machiels
Page
of 18